BCHE and Cognitive impairment: It was found that eseridine, physostigmine, physovenine, and eseramine can be predicted with a probability Pa of more than 0.5 for their dual MOAs (inhibition of acetylcholinesterase and butyrylcholinesterase) and pharmacological effects related to the treatment of VaD (cognition disorder treatment and nootropic).